However, this was unlikely a result of transdifferentiation to a variant prostate cancer state as we did not appreciate morphologic changes, loss of AR and PSMA expression53, or gain of SYP expression (Supplementary Fig. 7d). The gene discussed is SYP; the disease is prostate carcinoma.